Dealer Receives Maximum Sentence
In a Los Angeles federal court, Jaisvin Sangsi has been sentenced to 15 years in prison for distributing the drugs that led to actor Matthew Perry's death in October 2023. This is the harshest penalty among the five individuals charged in the case. Judge Sherilyn Peace Garnett noted that Sangsi continued her illicit activities even after another client died in 2019, demonstrating a reckless disregard for human life.
Case Details and Broader Impact
Jaisvin Sangsi, 42, pleaded guilty to distributing the substances that caused the death of Matthew Perry. The 54-year-old actor died from the acute effects of ketamine, which led to unconsciousness and drowning in his hot tub, according to the coroner's report. Perry's final purchase of the drug reportedly cost him $6,000 in cash. In a related case, Dr. Salvador Plascencia received a 2.5-year sentence for his role.
The two-year investigation gathered substantial evidence against Sangsi's operation. Matthew Perry's stepfather, journalist Keith Morrison, expressed the
"devastating grief the family is experiencing". His stepmother, Debbie Perry, stated that
"Sangsi's actions caused pain to thousands of people". Sangsi's attorney, Mark Geragos, represented her in court, where not only Sangsi but also Dr. Mark Chavez was found culpable; Chavez pleaded guilty in the actor's death.
This high-profile case has drawn significant public attention, highlighting not just a personal tragedy but also the pervasive issue of substance abuse and illicit drug networks affecting even prominent figures. The sentencing of Jaisvin Sangsi marks a significant step in legal efforts to combat the deadly trade of narcotics.
Sangsi's lengthy prison term may serve as a stark warning to others in the drug trade, underscoring the severe consequences of distributing dangerous substances. Cases like this underscore the need for stronger measures against drug trafficking and better support for those struggling with addiction. It also raises critical questions about the responsibility of medical professionals in treating and monitoring patients who may abuse prescription or illicit drugs.